Lifordi Immunotherapeutics

Website

Developer of targeted antibody-drug conjugates (ADCs) designed to treat autoimmune and inflammatory disorders. The company offers a proprietary ADC platform demonstrating enhanced efficacy and safety ...

Healthcare
Burlington, MA, United States
23 employees
Website
Valuation
$0
Share Price
N/A
Total Raised
$112M
Last Round
N/A
Investors
+4 other investors
View all 4 investors
Valuation History
0 funding rounds on record
Cap Table
Ownership structure
Market Activity
Secondary transactions

Get the full picture

Create a free account to unlock Lifordi Immunotherapeutics's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required